Skip to content

ClassIntra® for Better Outcomes in Surgery - CIBOSurg

Implementation of Routine Recording of Intraoperative Adverse Events According to ClassIntra® During the Sign-out Phase of the WHO Surgical Safety Checklist Using a Multifaceted, Tailored Implementation Strategy: Protocol of a Collaborative Before- and After-cohort Project

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05818332
Acronym
CIBOSurg
Enrollment
1800
Registered
2023-04-18
Start date
2023-07-17
Completion date
2027-07-31
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Patient Safety

Keywords

Perioperative safety, sign-out, intraoperative adverse events, ClassIntra®, hybrid design

Brief summary

Intra- and postoperative adverse events (iAEs and pAEs) occur in up to one third of all patients undergoing surgery. They are devastating to patients and costly to health care systems. Their number tends to increase due to the rising complexity of both the patient's risk profile and the surgical procedure. Postoperative deaths have been identified to be the third most frequent cause of death worldwide. Teamwork in surgery has been attributed to have a potentially great impact on avoiding postoperative morbidity. Up to 50% of all adverse in-hospital events were rated to be potentially preventable. However, their prevention typically requires a change in systems and individual behaviour. Standardised assessments of iAEs and pAEs are a prerequisite to develop and define strategies for prevention of AEs. While awareness of pAEs has highly risen through the introduction of the Clavien-Dindo classification, the most widely used classification for grading severity of pAEs, the relevance of transparent monitoring of iAEs is still highly undervalued.

Interventions

OTHERObservational study

No intervention, observational only

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

\- All in-hospital patients (consecutive or random sample) undergoing surgery from general surgery, vascular, surgery, orthopaedics/traumatology and urology in the operating room with anaesthesia involvement

Exclusion criteria

* Patients undergoing one-day-surgery (with or without anaesthesia-involvement) * Procedures without anaesthesia-involvement (in- or out-patient) * ASA risk classification (ASA) VI patients (brain-death, organ-donor) * Follow-up procedure of a patient already included in the study

Design outcomes

Primary

MeasureTime frameDescription
Intervention fidelity - component checklist completion2 months after the end of the implementationChecklist completion is defined as completeness of all ticks on the sign-out checklist taking into consideration the minimum standard.

Secondary

MeasureTime frameDescription
Implementation fidelity - Quantitative and qualitative evaluation of critical implementation stepsUp to four months after the implementationQuantitative and qualitative evaluation of critical implementation steps followed or not (and why not) by each site, according to the proposed/designed implementation plan (template)
Intervention acceptability - extent of perception among stakeholders that the intervention is agreeable or satisfactoryMeasured after the implementationAcceptability is the extent of perception among stakeholders that the intervention is agreeable or satisfactory. It will be measured according to the Acceptability of Intervention Measure (AIM).
Adaptation - extent to which sign-out and documentation of iAEs have been locally adaptedChecklist and process modifications classified according to FRAME.Adaptation is the extent to which sign-out and documentation of iAEs have been locally adapted. It will be measured by comparing the local checklists with the minimum standard sign-out.
Intervention fidelity - component quality of checklist performanceUp to four months after the implementationQuality of the sign-out will be measured with the WHO behaviourally anchored rating scale (WHOBARS): Quality will be measured in a random sample of 20-25%, assessed in those centres with well-established sign-out in the baseline period and in all centres in the after-implementation phase.
Feasibility - extent to which sign-out and documentation of iAEs can be successfully used or carried out within a given settingMeasured after the implementationFeasibility is the extent to which sign-out and documentation of iAEs can be successfully used or carried out within a given setting. It will be measured by the Feasibility of Intervention Measure FIM.
Sustainment12 months after the last patient outSustainment is measured by comparing (full) adherence (defined as completeness of all ticks on the sign-out checklist) 12 months after implementation
Appropriateness - extent to which staff perceive the intervention as being a good fit, relevant and compatible with their settingMeasured after the implementationAppropriateness is the extent to which staff perceive the intervention as being a good fit, relevant and compatible with their setting. It will be measured by the Intervention Appropriateness Measure (IAM).

Other

MeasureTime frameDescription
Qualitative conclusionsLongitudinal data collection before, during and after the implementationQualitative conclusions about the effectiveness of the employed implementation strategy.
Length of hospital stayDifference in length of hospital stay before and after the implementationLength of hospital stay will be measured in days.
Characterising themesLongitudinal data collection before, during and after the implementationThemes characterising the factors that influenced the observed implementation processes, based on the results from the contextual analysis.
Comprehensive Complication Index (CCI®)Difference in CCI® before and after the implementation at hospital discharge and at 90 days after surgeryCCI® (Comprehensive Complication Index) is the weighted sum of all pAEs according to Clavien-Dindo. It will be assessed at hospital discharge and at 90 days after surgery.
Severe iAEs according to ClassIntra®Difference in number of severe iAEs before and after the implementationSevere iAEs according to ClassIntra® are defined as greater than or equal to grade III.
Total number of iAEs according to ClassIntra®Difference in total number of iAEs before and after the implementationTotal number of iAEs according to ClassIntra® occurring in the baseline and the after implementation period.
Severe pAEs according to Clavien-DindoDifference in number of severe iAEs before and after the implementationSevere pAEs according to Clavien-Dindo are defined as greater than or equal to grade IIIa. They will be assessed at hospital discharge and at 90 days after surgery.
Total number of pAEs according to Clavien-DindoDifference in total number of pAEs before and after the implementationTotal number of pAEs according to Clavien-Dindo occurred in the baseline and the after implementation period. They will be assessed at hospital discharge and at 90 days after surgery.
Number of resulting actions due to the routine recording and discussion of iAEs during the sign-outDifference in number of resulting actions before and after the implementationResulting actions are e.g. preventive measures for anticipated pAEs.

Countries

Netherlands, Switzerland

Contacts

Primary ContactSalome Dell-Kuster, Prof. Dr. med.
salome.dell-kuster@usb.ch+41 61 328 64 74

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026